General Research #109166 >>>/qresearch/15150232
Aspen in South Africa to produce J&J jab
Johnson & Johnson’s decision to provide a licensing agreement to South African company Aspen Pharmacare to produce its COVID-19 vaccine is a “significant game changer for the continent,” according to Stavros Nicolaou, group senior executive of strategic trade development at Aspen. This makes it the first African company to have the right for distribution of a COVID-19 vaccine.
“This now means that Africa has its first COVID vaccine. It means that we would now determine both the availability, allocation, and distribution of the vaccine,” Nicolaou said Monday during an Africa Centres for Disease Control and Prevention stakeholder meeting on vaccine manufacturing.
6 December 2021
Johnson & Johnson’s decision to provide a licensing agreement to South African company Aspen Pharmacare to produce its COVID-19 vaccine is a “significant game changer for the continent,” according to Stavros Nicolaou, group senior executive of strategic trade development at Aspen. This makes it the first African company to have the right for distribution of a COVID-19 vaccine.
“This now means that Africa has its first COVID vaccine. It means that we would now determine both the availability, allocation, and distribution of the vaccine,” Nicolaou said Monday during an Africa Centres for Disease Control and Prevention stakeholder meeting on vaccine manufacturing.
https://www.devex.com/news/aspen-s-covid-19-vaccine-licensing-deal-a-game-changer-for-africa-102266